Let’s start up with the current stock price of VBI Vaccines Inc. (VBIV), which is $0.77 to be very precise. The Stock rose vividly during the last session to $0.8138 after opening rate of $0.6997 while the lowest price it went was recorded $0.68 before closing at $0.67.Recently in News on June 7, 2022, VBI Vaccines to Participate in the Jefferies Healthcare Conference. VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, VBI’s President and CEO, will participate in an analyst-led fireside chat at the Jefferies Healthcare Conference on Wednesday, June 8, 2022. You can read further details here
VBI Vaccines Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.4700 on 01/03/22, with the lowest value was $0.6405 for the same time period, recorded on 06/15/22.
VBI Vaccines Inc. (VBIV) full year performance was -79.94%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, VBI Vaccines Inc. shares are logging -82.22% during the 52-week period from high price, and 19.64% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.64 and $4.31.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 4005933 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the VBI Vaccines Inc. (VBIV) recorded performance in the market was -67.25%, having the revenues showcasing -50.56% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 195.30M, as it employees total of 149 workers.
The Analysts eye on VBI Vaccines Inc. (VBIV)
During the last month, 0 analysts gave the VBI Vaccines Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3272, with a change in the price was noted -0.85. In a similar fashion, VBI Vaccines Inc. posted a movement of -52.70% for the period of last 100 days, recording 2,325,232 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for VBIV is recording 0.23 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.19.
Technical rundown of VBI Vaccines Inc. (VBIV)
Raw Stochastic average of VBI Vaccines Inc. in the period of last 50 days is set at 11.34%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 31.49%. In the last 20 days, the company’s Stochastic %K was 15.29% and its Stochastic %D was recorded 10.94%.
Considering, the past performance of VBI Vaccines Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -67.25%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -69.22%, alongside a downfall of -79.94% for the period of the last 12 months. The shares increased approximately by 12.67% in the 7-day charts and went up by -21.01% in the period of the last 30 days. Common stock shares were lifted by -50.56% during last recorded quarter.